Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yasunobu Hirotsu is active.

Publication


Featured researches published by Yasunobu Hirotsu.


Modern Pathology | 2007

A micropapillary pattern is predictive of a poor prognosis in lung adenocarcinoma, and reduced surfactant apoprotein A expression in the micropapillary pattern is an excellent indicator of a poor prognosis

Hideaki Tsutsumida; Mitsuharu Nomoto; Masamichi Goto; Shinichi Kitajima; Ichiro Kubota; Yasunobu Hirotsu; Joeji Wakimoto; Michael A. Hollingsworth; Suguru Yonezawa

A micropapillary pattern is defined as papillary tufts without a fibrovascular core and is known to be a factor that indicates a poor prognosis in numerous cancers. However, their role in lung adenocarcinoma has not been investigated widely. In 185 cases of small-size lung adenocarcinoma (≤3 cm), cases with a micropapillary pattern ratio of more than 1% (analyzed by NIH image) were defined as micropapillary pattern positive. Correlations between the micropapillary pattern and clinicopathological factors were investigated and immunohistochemical expression of mucin and various antigens was examined in regions with and without micropapillary patterns. Micropapillary pattern-positive tumors (micropapillary pattern ratio ≥1%) were observed in 11.4% of cases (21/185) and the micropapillary pattern ratio correlated with TNM stage (P=0.0002), lymphatic invasion (P=0.0002) and lymph node metastasis (P=0.03). Disease-free interval (P<0.0002) and survival (P=0.027) were significantly shorter for micropapillary pattern-positive patients, and micropapillary pattern-positive stage IA cases also had a significantly shorter disease-free interval (P<0.0001). MUC1 was expressed strongly across the surface of the micropapillary structure, whereas MUC4 tended to show lower expression in the micropapillary pattern. It was noteworthy that the disease-free interval in patients with high surfactant apoprotein A expression was significantly better than in patients with low surfactant apoprotein A expression (P=0.03), and no recurrence or death occurred in patients with high surfactant apoprotein A expression. Our results show that the micropapillary pattern ratio correlates with lymphatic invasion and lymph node metastasis, and that a high micropapillary pattern ratio leads to a poor prognosis. High MUC1 expression on the surface is an important characteristic of a micropapillary pattern, and reduced surfactant apoprotein A expression in the micropapillary pattern may be an excellent indicator for poor prognosis in small-size lung adenocarcinoma.


Histopathology | 2004

Combined status of MUC1 mucin and surfactant apoprotein A expression can predict the outcome of patients with small-size lung adenocarcinoma

Hideaki Tsutsumida; Masamichi Goto; Shinichi Kitajima; Ichiro Kubota; Yasunobu Hirotsu; Suguru Yonezawa

Aim : Lung cancer is still a disease of high mortality, despite advanced diagnostic techniques. Here, we aim to report a unique method to predict the recurrence and outcome of patients with pulmonary adenocarcinomas.


Annals of Nuclear Medicine | 1988

Increased accumulation of iodine-123-IMP in the pulmonary inflammatory lesion surrounding a lung cancer

Masayuki Nakajo; Noriaki Uchiyama; Yoshiyuki Hiraki; Yoshihiko Miyata; Atsuhisa Iriki; Yasunobu Hirotsu; Joeji Wakimoto; Yoshimasa Norimatsu

In a patient with primary lung cancer, increased accumulation of I-123-IMP was observed in a pulmonary inflammatory lesion surrounding a lung cancer which was delineated as a photon deficient area. Ga-67-citrate uptake was observed in both the inflammatory and cancerous areas. These findings suggest that I-123-IMP may have the potential to accumulate differently in a variety of pathological conditions of the lung and thus may be a clinically useful lung imaging agent.


Annals of Nuclear Medicine | 1990

Differentiation of bronchogenic carcinoma from secondary changes, obstructive pneumonitis and/or collapse by I-123 IMP lung imaging.

Masayuki Nakajo; Noriaki Uchiyama; Jurio Shimada; Shinji Shinohara; Atsushi Iriki; Yasunobu Hirotsu; Katsushi Egawa; Hidetomo Fukunaga; Yoshimasa Norimatsu

Serial lung images with N-isopropyl-p-[I-123]-iodoamphetamine (I-123 IMP) were obtained to assess the imaging findings and to clarify the lesion to uptake relationships in 74 lesions in 73 patients with various histological types of bronchogenic carcinoma. A decreased uptake area was observed in all 74 lesions in the initial one or two-min I-123 IMP image. The initial image was analogous to a Tc-99m MAA lung perfusion image in 70 patients in whom both lung imaging procedures were performed. The imaging findings changed following this initial phase. At 4 hr, the lesion was depicted as either areas of decreased uptake or increased uptake or a combination of the two. Comparison between the lesion findings in the 4-hr I-123 IMP images, radiograms and removed specimens revealed that areas of decreased uptake corresponded to the cancerous portions of the lung mass or pleural effusion and areas of increased uptake corresponded to inflammatory portions including obstructive pneumonitis and/or collapse. Thus, the 4-hr I-123 IMP lung images can be used to discriminate the cancerous portion from associated secondary changes, obstructive pneumonitis and/or collapse.


American Journal of Respiratory and Critical Care Medicine | 2000

Increased serum level of vascular endothelial growth factor in pulmonary tuberculosis.

Wataru Matsuyama; Teruto Hashiguchi; Kenji Matsumuro; Fumiyuki Iwami; Yasunobu Hirotsu; Masaharu Kawabata; Kimiyoshi Arimura; Mitsuhiro Osame


Human Mutation | 2003

Mitochondrial DNA Mutation Correlates With Stage Progression and Prognosis in Non-small Cell Lung Cancer

Wataru Matsuyama; Masanori Nakagawa; Joeji Wakimoto; Yasunobu Hirotsu; Masaharu Kawabata; Mitsuhiro Osame


Lung Cancer | 2007

MUC4 expression correlates with poor prognosis in small-sized lung adenocarcinoma

Hideaki Tsutsumida; Masamichi Goto; Shinichi Kitajima; Ichiro Kubota; Yasunobu Hirotsu; Joeji Wakimoto; Surinder K. Batra; Kohzoh Imai; Suguru Yonezawa


Internal Medicine | 2001

Expression of Vascular Endothelial Growth Factor in Pulmonary Aspergilloma

Koji Inoue; Wataru Matsuyama; Teruto Hashiguchi; Joeji Wakimoto; Yasunobu Hirotsu; Masaharu Kawabata; Kimiyoshi Arimura; Mitsuhiro Osame


Internal Medicine | 1999

Bronchiectasis with Myeloperoxidase Antineutrophil Cytoplasmic Antibody and Bactericidal/Permeability-Increasing Protein Antineutrophil Cytoplasmic Antibody

Wataru Matsuyama; Joeji Wakimoto; Akira Watanabe; Ichirou Kubota; Yasunobu Hirotsu; Akira Mizoguchi; Fumiyuki Iwami; Masaharu Kawabata; Mitsuhiro Osame


Chest | 1992

Inflammatory pseudotumor arising from the hilum and invading the subepithelium.

Fumiyuki Iwami; Yasunobu Hirotsu; Joji Wakimoto; Hidetomo Fukunaga

Collaboration


Dive into the Yasunobu Hirotsu's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge